Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application

Article Type
Article
Changed
Display Headline
Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application
Author(s)
Kalainov DM
Valentino LA

Article PDF
037110572.pdf
Author and Disclosure Information

David M. Kalainov, MD, and Leonard A. Valentino, MD

Dr. Kalainov is Assistant Professor, Clinical Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Dr. Valentino is Associate Professor, Pediatrics and Internal Medicine, and Director, Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois.

Issue
The American Journal of Orthopedics - 37(11)
Publications
The American Journal of Orthopedics
MDedge Surgery
Topics
Practice Management
Business of Medicine
Orthopedics
Page Number
572-574
Legacy Keywords
recombinant activated factor VII, warfarin, anticoagulation, thromboembolism, pulmonary emboli, vitamin k antagonist, shoulder, off label, application, ajo, american journal of orthopedics
Sections
Case Reports
Author(s)
Kalainov DM
Valentino LA
Author(s)
Kalainov DM
Valentino LA
Author and Disclosure Information

David M. Kalainov, MD, and Leonard A. Valentino, MD

Dr. Kalainov is Assistant Professor, Clinical Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Dr. Valentino is Associate Professor, Pediatrics and Internal Medicine, and Director, Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois.

Author and Disclosure Information

David M. Kalainov, MD, and Leonard A. Valentino, MD

Dr. Kalainov is Assistant Professor, Clinical Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Dr. Valentino is Associate Professor, Pediatrics and Internal Medicine, and Director, Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois.

Article PDF
037110572.pdf
Article PDF
037110572.pdf

Issue
The American Journal of Orthopedics - 37(11)
Issue
The American Journal of Orthopedics - 37(11)
Page Number
572-574
Page Number
572-574
Publications
The American Journal of Orthopedics
MDedge Surgery
Publications
The American Journal of Orthopedics
MDedge Surgery
Topics
Practice Management
Business of Medicine
Orthopedics
Article Type
Article
Display Headline
Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application
Display Headline
Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application
Legacy Keywords
recombinant activated factor VII, warfarin, anticoagulation, thromboembolism, pulmonary emboli, vitamin k antagonist, shoulder, off label, application, ajo, american journal of orthopedics
Legacy Keywords
recombinant activated factor VII, warfarin, anticoagulation, thromboembolism, pulmonary emboli, vitamin k antagonist, shoulder, off label, application, ajo, american journal of orthopedics
Sections
Case Reports
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Kalainov DM